Advanced Flower Capital (AFCG) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
7 May, 2026Executive summary
Completed transition to a business development company (BDC) effective January 1, 2026, expanding investment flexibility and focus beyond cannabis to broader lower middle-market sectors and ancillary industries.
Closed two non-cannabis lower middle market deals totaling $90 million in new commitments, with gross investment fundings of $80.9 million and net fundings of $39.1 million for Q1 2026.
Portfolio expanded to 17 companies by May 1, 2026, with $370 million principal balance outstanding and $380.7 million in commitments.
Three loans on nonaccrual status, representing 23.5% of total debt investments at fair value, with ongoing legal proceedings and forbearance agreements.
Leadership team with extensive experience in credit, asset management, and public company operations, supporting disciplined underwriting and portfolio management.
Financial highlights
Net investment income for Q1 2026 was $4.8 million ($0.21 per share), with total investment income of $9.8 million.
Net asset value per share increased to $7.90 as of March 31, 2026, up from $7.46 at year-end 2025.
Net increase in net assets from operations was $11.4 million ($0.49 per share) for Q1 2026.
Board declared and paid a Q1 2026 distribution of $0.05 per share on April 15, 2026.
Portfolio investments at fair value totaled $279.2 million as of March 31, 2026.
Outlook and guidance
BDC structure enables broader industry diversification, increased leverage, and more flexible loan structuring, positioning for growth in direct lending to lower middle-market companies.
Management expects continued portfolio diversification and origination activity in both cannabis and non-cannabis sectors.
Sufficient liquidity and capital resources to meet operating requirements for at least the next twelve months.
Dry powder available for deployment, but no specific guidance on loan growth for the remainder of the year.
Focus remains on disciplined origination, active portfolio management, and maintaining strong liquidity and asset coverage.
Latest events from Advanced Flower Capital
- BDC conversion expanded investment scope; $1.4B pipeline, $366M principal outstanding in 2025.AFCG
Q4 202527 Apr 2026 - Cannabis lending platform delivers 20% yields and strong dividends amid rapid industry growth.AFCG
Investor presentation24 Apr 2026 - Board recommends director elections and auditor ratification, with strong governance and oversight.AFCG
Proxy filing17 Apr 2026 - Vote on director elections and auditor ratification at the May 2026 annual meeting.AFCG
Proxy filing17 Apr 2026 - Q2 2025 net loss of $13.2M, $3.4M distributable earnings, and BDC conversion planned.AFCG
Q2 202510 Mar 2026 - Q2 net income reached $16.4M as the company became a pure-play cannabis lender.AFCG
Q2 20242 Feb 2026 - Q3 2024 earnings met targets, with strong originations and higher risk post-CRE spin-off.AFCG
Q3 202414 Jan 2026 - Exceeded origination targets, delivered strong yields, and maintained a robust pipeline.AFCG
Q4 202424 Dec 2025 - REIT lender to cannabis sector files $1B shelf registration for flexible equity and debt offerings.AFCG
Registration Filing16 Dec 2025